304 filings
Page 3 of 16
8-K
v1scfw2gj 7bb
11 Aug 22
HTG Molecular Diagnostics Reports Second Quarter 2022 Results
4:16pm
8-K
8zc9f4m3qqf
18 Jul 22
Entry into a Material Definitive Agreement
8:30am
DEFA14A
xkrg feb5
7 Jul 22
Additional proxy soliciting materials
4:15pm
8-K
xymppf
27 Jun 22
Departure of Directors or Certain Officers
4:00pm
8-K
gvtzkzb2
9 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
xcfl7bn2
12 May 22
HTG Molecular Diagnostics Reports First Quarter 2022 Results
4:21pm
EFFECT
l4bs6nq6he79
20 Apr 22
Notice of effectiveness
12:15am
CORRESP
ij2sdx6 kqz0fort
15 Apr 22
Correspondence with SEC
12:00am
UPLOAD
ymg5s4gt37
14 Apr 22
Letter from SEC
12:00am
8-K
gb0k9t nblya4
29 Mar 22
HTG Molecular Diagnostics Reports Full Year 2021 Results
4:10pm
D
7zsih3 0d58
25 Mar 22
$20.88M in equity / options / securities to be acquired, sold $7.5M, 1 investor
4:10pm
8-K
uch6lz7x34gy0 z5lmv
21 Mar 22
Unregistered Sales of Equity Securities
5:11pm
EFFECT
z8cpuphz uj7i0uss5dd
3 Feb 22
Notice of effectiveness
12:15am
UPLOAD
rsnoh7h b49ylsd
31 Jan 22
Letter from SEC
12:00am
CORRESP
41lxh2 zyepk1e0clc
31 Jan 22
Correspondence with SEC
12:00am